Northern Lights Fund Trust III Swan Enhanced Dividend Income ETF (BATS: SCLZ)

Northern Lights Fund Trust III Swan Enhanced Dividend Income ETF (BATS:SCLZ), Trade Ideas

Northern Lights Fund Trust III Swan Enhanced Dividend Income ETF

Scales Corp Ltd

<p>Atara Biotherapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATRA#NASDAQ">ATRA</a>) reported quarterly losses of $(0.23) per share which beat the analyst consensus estimate of $(0.25) by 8 percent.</p>


Earnings

Earnings Beats

News

ATRA

Atara Biotherapeutics Q1 2024 GAAP EPS $(0.23) Beats $(0.25) Estimate

<p>Collegium Pharmaceutical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COLL#NASDAQ">COLL</a>) reported quarterly earnings of $1.45 per share which beat the analyst consensus estimate of $0.73 by 98.63 percent. This is a 9.85 percent increase over earnings of $1.32 per share from the same period last year.  The company reported quarterly sales of $144.923 million which missed the analyst consensus estimate of $146.853 million by 1.31 percent.  This is a 0.11 percent increase over sales of $144.767 million the same period last year.</p>


Earnings Misses

COLL

Collegium Pharmaceutical Q1 2024 Adj EPS $1.45 Beats $0.73 Estimate, Sales $144.923M Miss $146.853M Estimate

<p>Dianthus Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DNTH#NASDAQ">DNTH</a>) reported quarterly losses of $(0.54) per share which missed the analyst consensus estimate of $(0.44) by 22.73 percent.  The company reported quarterly sales of $874.00 thousand which beat the analyst consensus estimate of $460.00 thousand by 90.00 percent.</p>


DNTH

Dianthus Therapeutics Q1 EPS $(0.54) Misses $(0.44) Estimate, Sales $874.00K Beat $460.00K Estimate

Guidance

GRPN

Groupon Sees FY24 Revenue $489M-$515M Vs $522.851M Est.

<p>Investors with a lot of money to spend have taken a bullish stance on <strong>GE Vernova</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GEV#NYSE">GEV</a>).</p>
<p>And retail traders should know.</p>
<p>We noticed this today when the positions showed up on publicly available options history that we track here at Benzinga.</p>
<p>Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with GEV, it often means somebody knows something is about to happen.</p>
<p>Today, Benzinga's options scanner spotted 14 options trades for <strong>GE Vernova</strong>.</p>
<p>This isn't normal.</p>
<p>The overall sentiment of these big-money traders is split between 57% bullish and 42%, bearish.</p>
<p>Out of all of the options we uncovered, there was 1 put, for a total amount of $39,500, and 13, calls, for a total amount of $661,413.</p>
<h3>Projected Price Targets</h3>
<p>Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $145.0 to $200.0 for GE Vernova over the recent three months. </p>
<h3>Analyzing Volume &amp; Open Interest</h3>
<p>Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in GE Vernova's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to GE Vernova's substantial trades, within a strike price spectrum from $145.0 to $200.0 over the preceding 30 days.</p>
<h3>GE Vernova Option Volume And Open Interest Over Last 30 Days</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1715287585_0.png" alt="Options Call Chart" /></p>
<h3>Biggest Options Spotted:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th style="text-align: right;"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>GEV</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>07/19/24</td>
<td>$8.8</td>
<td>$8.4</td>
<td>$8.8</td>
<td>$175.00</td>
<td>$88.0K</td>
<td>1.6K</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>GEV</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$21.7</td>
<td>$21.5</td>
<td>$21.6</td>
<td>$180.00</td>
<td>$77.7K</td>
<td>60</td>
<td style="text-align: right;">382</td>
</tr>
<tr>
<td>GEV</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/21/24</td>
<td>$1.45</td>
<td>$1.2</td>
<td>$1.3</td>
<td>$200.00</td>
<td>$64.7K</td>
<td>1.0K</td>
<td style="text-align: right;">500</td>
</tr>
<tr>
<td>GEV</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>07/19/24</td>
<td>$9.0</td>
<td>$8.9</td>
<td>$9.0</td>
<td>$175.00</td>
<td>$63.0K</td>
<td>1.6K</td>
<td style="text-align: right;">323</td>
</tr>
<tr>
<td>GEV</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>06/21/24</td>
<td>$10.3</td>
<td>$9.5</td>
<td>$10.3</td>
<td>$165.00</td>
<td>$61.8K</td>
<td>118</td>
<td style="text-align: right;">61</td>
</tr>
</tbody>
</table>
</p>
<h3>About GE Vernova</h3>
<p>GE Vernova is a global leader in the electric power industry, with products and services that generate, transfer, convert, and store electricity. The company has three business segments: power, wind, and electrification. Power includes gas, nuclear, hydroelectric, and steam technologies, providing dispatchable power. The wind segment includes wind generation technologies, inclusive of onshore and offshore wind turbines and blades. Electrification includes grid solutions, power conversion, electrification software, and solar and storage solutions technologies required for the transmission, distribution, conversion, and storage of electricity from the point of generation to point of consumption.</p>
<p>Having examined the options trading patterns of GE Vernova, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance</p>
<h3>Where Is GE Vernova Standing Right Now?</h3>
<ul>
<li>Trading volume stands at 3,999,838, with GEV's price up by 1.79%, positioned at $166.93.</li>
<li>RSI indicators show the stock to be is currently neutral between overbought and oversold.</li>
<li>Earnings announcement expected in 12 days.</li>
</ul>
<h3>What The Experts Say On GE Vernova</h3>
<p>Over the past month, 5 industry analysts have shared their insights on this stock, proposing an average target price of $157.6.</p>
<ul>
<li>An analyst from B of A Securities has revised its rating downward to Neutral, adjusting the price target to $150. </li>
<li>Consistent in their evaluation, an analyst from Mizuho keeps a Buy rating on GE Vernova with a target price of $164. </li>
<li>In a cautious move, an analyst from Raymond James downgraded its rating to Outperform, setting a price target of $160. </li>
<li>An analyst from Mizuho downgraded its action to Buy with a price target of $154. </li>
<li>Consistent in their evaluation, an analyst from B of A Securities keeps a Neutral rating on GE Vernova with a target price of $160. </li>
</ul>
<p>Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for GE Vernova with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.</p>


Options

Markets

GE Vernova's Options Frenzy: What You Need to Know

Groupon Sees Q2 2024 Revenue $116M-$122M Vs $122.647M Est.

<p>Investors with a lot of money to spend have taken a bullish stance on <strong>Emerson Electric</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EMR#NYSE">EMR</a>).</p>
<p>And retail traders should know.</p>
<p>We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.</p>
<p>Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with EMR, it often means somebody knows something is about to happen.</p>
<p>So how do we know what these investors just did? </p>
<p>Today, <a href="https://pro.benzinga.com/?utm_source=insights">Benzinga</a>'s options scanner spotted 12 uncommon options trades for Emerson Electric.</p>
<p>This isn't normal.</p>
<p>The overall sentiment of these big-money traders is split between 41% bullish and 41%, bearish.</p>
<p>Out of all of the special options we uncovered, 2 are puts, for a total amount of $278,020, and 10 are calls, for a total amount of $598,254.</p>
<h3>Expected Price Movements</h3>
<p>After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $105.0 and $130.0 for Emerson Electric, spanning the last three months.</p>
<h3>Insights into Volume &amp; Open Interest</h3>
<p>Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Emerson Electric's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Emerson Electric's substantial trades, within a strike price spectrum from $105.0 to $130.0 over the preceding 30 days.</p>
<h3>Emerson Electric Option Volume And Open Interest Over Last 30 Days</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1715287580_0.png" alt="Options Call Chart" /></p>
<h3>Significant Options Trades Detected:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th style="text-align: right;"><strong>Open Interest</strong></th>
<th style="text-align: right;"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>EMR</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>06/07/24</td>
<td>$12.0</td>
<td>$9.1</td>
<td>$10.65</td>
<td>$105.00</td>
<td>$171.4K</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">1</td>
</tr>
<tr>
<td>EMR</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$11.2</td>
<td>$8.9</td>
<td>$11.2</td>
<td>$120.00</td>
<td>$140.0K</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">125</td>
</tr>
<tr>
<td>EMR</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$6.9</td>
<td>$6.7</td>
<td>$6.9</td>
<td>$115.00</td>
<td>$138.0K</td>
<td style="text-align: right;">404</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>EMR</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>09/20/24</td>
<td>$2.0</td>
<td>$1.75</td>
<td>$1.95</td>
<td>$125.00</td>
<td>$132.6K</td>
<td style="text-align: right;">535</td>
<td style="text-align: right;">409</td>
</tr>
<tr>
<td>EMR</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>09/20/24</td>
<td>$1.9</td>
<td>$1.85</td>
<td>$1.85</td>
<td>$125.00</td>
<td>$46.2K</td>
<td style="text-align: right;">535</td>
<td style="text-align: right;">4</td>
</tr>
</tbody>
</table>
</p>
<h3>About Emerson Electric</h3>
<p>Emerson Electric sells automation equipment and services under two segments: intelligent devices and software control. Within software and control, it also holds a majority interest in AspenTech, an industrial software business, and owns a test and measurement business that was formerly National Instruments. Intelligent devices also holds Emerson's tools business, which boasts several household brands, like Ridgid. Emerson's automation business is most known for its process manufacturing solutions, which consists of measurement and analytical instrumentation, as well as control valves and actuators, among other products and services. Nearly half of the firm's geographic sales come from the Americas.</p>
<p>Having examined the options trading patterns of Emerson Electric, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance</p>
<h3>Where Is Emerson Electric Standing Right Now?</h3>
<ul>
<li>With a volume of 4,606,936, the price of EMR is up 2.61% at $115.59. </li>
<li>RSI indicators hint that the underlying stock may be approaching overbought.</li>
<li>Next earnings are expected to be released in 83 days.</li>
</ul>
<h3>What The Experts Say On Emerson Electric</h3>
<p>In the last month, 3 experts released ratings on this stock with an average target price of $129.66666666666666.</p>
<ul>
<li>An analyst from Mizuho has decided to maintain their Buy rating on Emerson Electric, which currently sits at a price target of $135. </li>
<li>Consistent in their evaluation, an analyst from Baird keeps a Neutral rating on Emerson Electric with a target price of $116. </li>
<li>An analyst from Deutsche Bank upgraded its action to Buy with a price target of $138. </li>
</ul>
<p>Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Emerson Electric options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.</p>


Emerson Electric's Options: A Look at What the Big Money is Thinking

<p>Whales with a lot of money to spend have taken a noticeably bearish stance on <strong>Pfizer</strong>.</p>
<p>Looking at options history for Pfizer (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PFE#NYSE">PFE</a>) we detected 27 trades.</p>
<p>If we consider the specifics of each trade, it is accurate to state that 29% of the investors opened trades with bullish expectations and 59% with bearish.</p>
<p>From the overall spotted trades, 12 are puts, for a total amount of $634,798 and 15, calls, for a total amount of $760,655.</p>
<h3>Expected Price Movements</h3>
<p>After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $15.0 and $32.5 for Pfizer, spanning the last three months.</p>
<h3>Analyzing Volume &amp; Open Interest</h3>
<p>Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Pfizer's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Pfizer's significant trades, within a strike price range of $15.0 to $32.5, over the past month.</p>
<h3>Pfizer Option Activity Analysis: Last 30 Days</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1715287575_0.png" alt="Options Call Chart" /></p>
<h3>Significant Options Trades Detected:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>PFE</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>07/19/24</td>
<td>$0.73</td>
<td>$0.71</td>
<td>$0.71</td>
<td>$29.00</td>
<td>$174.1K</td>
<td>11.9K</td>
<td>3.2K</td>
</tr>
<tr>
<td>PFE</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>09/20/24</td>
<td>$1.94</td>
<td>$1.92</td>
<td>$1.92</td>
<td>$27.50</td>
<td>$86.4K</td>
<td>57.6K</td>
<td>645</td>
</tr>
<tr>
<td>PFE</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>08/16/24</td>
<td>$1.74</td>
<td>$1.64</td>
<td>$1.64</td>
<td>$28.00</td>
<td>$82.0K</td>
<td>3.8K</td>
<td>700</td>
</tr>
<tr>
<td>PFE</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>08/16/24</td>
<td>$2.05</td>
<td>$2.02</td>
<td>$2.05</td>
<td>$27.00</td>
<td>$81.9K</td>
<td>5.7K</td>
<td>451</td>
</tr>
<tr>
<td>PFE</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>07/19/24</td>
<td>$0.19</td>
<td>$0.17</td>
<td>$0.18</td>
<td>$25.00</td>
<td>$76.9K</td>
<td>21.6K</td>
<td>175</td>
</tr>
</tbody>
</table>
</p>
<h3>About Pfizer</h3>
<p>Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding COVID-19 product sales). While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing close to 50% of total sales. Within international sales, emerging markets are a major contributor.</p>
<p>After a thorough review of the options trading surrounding Pfizer, we move to examine the company in more detail. This includes an assessment of its current market status and performance.</p>
<h3>Pfizer's Current Market Status</h3>
<ul>
<li>With a volume of 46,638,429, the price of PFE is up 1.15% at $28.17. </li>
<li>RSI indicators hint that the underlying stock may be approaching overbought.</li>
<li>Next earnings are expected to be released in 82 days.</li>
</ul>
<h3>Professional Analyst Ratings for Pfizer</h3>
<p>Over the past month, 4 industry analysts have shared their insights on this stock, proposing an average target price of $38.75.</p>
<ul>
<li>Reflecting concerns, an analyst from Cantor Fitzgerald lowers its rating to Overweight with a new price target of $45.</li>
<li>An analyst from BMO Capital has revised its rating downward to Outperform, adjusting the price target to $36. </li>
<li>An analyst from Morgan Stanley persists with their Equal-Weight rating on Pfizer, maintaining a target price of $29. </li>
<li>Reflecting concerns, an analyst from Cantor Fitzgerald lowers its rating to Overweight with a new price target of $45.</li>
</ul>
<p>Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.</p>
<p>If you want to stay updated on the latest options trades for Pfizer, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.</p>


Spotlight on Pfizer: Analyzing the Surge in Options Activity

CARG

CarGurus Expects Q2 Total Revenue Of $202M-$222M (Est $224.504M), Adj EPS Of $0.29-$0.34 (Est $0.30)

<p>Altus Power (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMPS#NYSE">AMPS</a>) reported quarterly earnings of $0.05 per share which beat the analyst consensus estimate of $(0.08) by 162.5 percent. This is a 66.67 percent increase over earnings of $0.03 per share from the same period last year.  The company reported quarterly sales of $40.659 million which beat the analyst consensus estimate of $39.920 million by 1.85 percent.  This is a 38.40 percent increase over sales of $29.378 million the same period last year.</p>


AMPS

Altus Power Q1 2024 GAAP EPS $0.05 Beats $(0.08) Estimate, Sales $40.659M Beat $39.920M Estimate

<p>Natural Grocers (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NGVC#NYSE">NGVC</a>) reported quarterly earnings of $0.35 per share. This is a 34.62 percent increase over earnings of $0.26 per share from the same period last year.  The company reported $308.092 million in sales this quarter. This is a 8.77 percent increase over sales of $283.245 million the same period last year.</p>


NGVC

Natural Grocers Q2 2024 GAAP EPS $0.35 Up From $0.26 YoY, Sales $308.092M Up From $283.245M YoY

<p>Research Frontiers (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/REFR#NASDAQ">REFR</a>) reported quarterly losses of $(0.01) per share. This is unchanged from the same period last year.  The company reported $313.38 thousand in sales this quarter. This is a 26.27 percent increase over sales of $248.18 thousand the same period last year.</p>


REFR

Research Frontiers Q1 EPS $(0.01), Same YoY, Sales $313.38K Up From $248.18K YoY

WIIM

Nelnet shares are trading higher after the company reported better-than-expected Q1 Adj. EPS results.

IBEX

IBEX Limited Sees FY24 Revenue $505M-$510M

<p>Ginkgo Bioworks Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DNA#NYSE">DNA</a>) reported quarterly losses of $(0.08) per share which beat the analyst consensus estimate of $(0.09) by 11.11 percent.  The company reported quarterly sales of $38.000 million which missed the analyst consensus estimate of $46.044 million by 17.47 percent.  This is a 52.91 percent decrease over sales of $80.702 million the same period last year.</p>


Ginkgo Bioworks Holdings Q1 2024 GAAP EPS $(0.08) Beats $(0.09) Estimate, Sales $38.000M Miss $46.044M Estimate

H&R Block shares are trading higher after the company reported better-than-expected Q3 financial results.

TREX

Trex Company Sees Q2 Revenues Of $380M-$390M, Est $375.233M

<p>Acacia Research (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACTG#NASDAQ">ACTG</a>) reported quarterly sales of $24.320 million which beat the analyst consensus estimate of $11.000 million by 121.09 percent.  This is a 64.29 percent increase over sales of $14.803 million the same period last year.</p>


ACTG

Acacia Research Q1 Sales $24.320M Beat $11.000M Estimate

Genpact shares are trading higher after the company reported better-than-expected Q1 financial results and raised its FY24 EPS range. Also, the company issued Q2 revenue guidance above estimates.